Paola Bottoni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Paola Bottoni has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Sergio Caroli
Società di Scienze Farmacologiche Applicate (Society of Applied Pharmacological Science), Viale Abruzzi 32, 20131 Milan, Italy
2 shared publications - Anna Barra Caracciolo
Water Research Institute, National Research Council (IRSA-CNR), Rome, Montelibretti, Italy
1 shared publication Gyula Záray
1 shared publication- Gyula Záray
MTA Centre for Ecological Research, Danube Research Institute, Budapest, Hungary
1 shared publication S. Caroli
Department of Food Safety and Veterinary Public Health , Istituto Superiore di Sanità , Rome, Italy
1 shared publicationSergio Caroli
1 shared publication
Latest Publications
- 7 September 2019
- Published by Elsevier in Microchemical Journal
- Vol. 151, 104224
Preface - Selected papers from the XVI Hungarian – Italian Symposium on Spectrochemistry
- 7 September 2019
- Published by Elsevier in Microchemical Journal
- Vol. 151, 104224
Preface - Selected papers from the XVI Hungarian – Italian Symposium on Spectrochemistry
- 1 March 2015
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 106, 1
Preface
- 1 March 2015
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 106, 1
Preface
- Open Access
- 12 March 2010
- Published by Taylor & Francis in Toxicological & Environmental Chemistry
- Vol. 92 (3) , 549-565
Pharmaceuticals as priority water contaminants
Pharmaceuticals and their metabolites can reach water bodies through sewage systems, industrial discharges, effluents from sewage treatment plants (STPs), aquaculture, and livestock farming. Pharmaceuticals include a hundred substances which are very different as regards chemical–physical properties and environmental behavior, although they may have strong biochemical activities. At present, pharmaceuticals can reach water concentrations of ng L−1 to µg L−1 and some are considered ubiquitous. Nevertheless, their presence in the aquatic environment and impact on aquatic biota and on human health have not yet been studied adequately. Experimental evidence indicates that pharmaceuticals may cause harmful effects, such as morphological, metabolic and sex alterations on aquatic species, induction of antibiotic resistance in aquatic pathogenic microorganisms, and disruption of biodegradation activities in STPs. Risk assessment studies and evaluations are in progress. Yet, the available scientific data are consistent with the introduction of some pharmaceutical indicators in extensive water monitoring to better define their actual impact on aquatic organisms and humans. Under these perspectives, the inclusion of emerging pharmaceuticals in the revision of EU List of Priority Substances under the Water Framework Directive 2000/60/EC should be implemented as well as the definition of respective environmental quality standards.
- 12 March 2010
- Published by Taylor & Francis in Toxicological & Environmental Chemistry
- Vol. 92 (3) , 549-565
Open AccessPharmaceuticals as priority water contaminants
Pharmaceuticals and their metabolites can reach water bodies through sewage systems, industrial discharges, effluents from sewage treatment plants (STPs), aquaculture, and livestock farming. Pharmaceuticals include a hundred substances which are very different as regards chemical–physical properties and environmental behavior, although they may have strong biochemical activities. At present, pharmaceuticals can reach water concentrations of ng L−1 to µg L−1 and some are considered ubiquitous. Nevertheless, their presence in the aquatic environment and impact on aquatic biota and on human health have not yet been studied adequately. Experimental evidence indicates that pharmaceuticals may cause harmful effects, such as morphological, metabolic and sex alterations on aquatic species, induction of antibiotic resistance in aquatic pathogenic microorganisms, and disruption of biodegradation activities in STPs. Risk assessment studies and evaluations are in progress. Yet, the available scientific data are consistent with the introduction of some pharmaceutical indicators in extensive water monitoring to better define their actual impact on aquatic organisms and humans. Under these perspectives, the inclusion of emerging pharmaceuticals in the revision of EU List of Priority Substances under the Water Framework Directive 2000/60/EC should be implemented as well as the definition of respective environmental quality standards.
- 12 March 2010
- Published by Taylor & Francis in Toxicological & Environmental Chemistry
- Vol. 92 (3) , 411
Foreword
(2010). Foreword. Toxicological & Environmental Chemistry: Vol. 92, XIII Italian-Hungarian Symposium on Spectrochemistry: Environmental Contamination and Food Safety (Bologna, April 20–24, 2008), pp. 411-411.
- 12 March 2010
- Published by Taylor & Francis in Toxicological & Environmental Chemistry
- Vol. 92 (3) , 411
Foreword
(2010). Foreword. Toxicological & Environmental Chemistry: Vol. 92, XIII Italian-Hungarian Symposium on Spectrochemistry: Environmental Contamination and Food Safety (Bologna, April 20–24, 2008), pp. 411-411.